Table 2.

A evaluation of the programmatic correlates leading to cervical cancer diagnoses. Abbreviations: SCC, squamous cell carcinoma, ADC, adenocarcinoma

Programmatic Correlates of Cervical Cancer Diagnoses	All n=623			SCC n=351			ADC n=212			Other Cancers n=19			Unknown‡ n=41			p*
	n	% col	% col′	n	% col	% col′	n	% col	% col′	n	% col	% col′	n	% col	% col′
Prevalent Cancers	360	57.8%	---	227	64.7%	---	101	47.6%	---	6	31.6%	---	26	63.4%	---	<0.001
Non-Prevalent Cancers	263	42.2%	100%	124	35.3%	100%	111	52.4%	100%	13	68.4%	100%	15	36.6%	100%	<0.001
False-Negative Cotest (Screen)	70	11.2%	26.6%	36	10.3%	29.0%	25	11.8%	22.5%	7	36.8%	53.8%	2	4.9%	13.3%	0.07
Algorithm Delays	48	7.7%	18.3%	15	4.3%	12.1%	29	13.7%	26.1%	2	10.5%	15.4%	2	4.9%	13.3%	0.04
False-Negative Diagnoses (Colposcopy and Biopsy)	56	9.0%	21.3%	20	5.7%	16.1%	28	13.2%	25.2%	3	15.8%	23.1%	5	12.2%	33.3%	0.2
Treatment Failure	27	4.3%	10.3%	23	6.6%	18.5%	3	1.4%	2.7%	0	0.0%	0.0%	1	2.4%	6.7%	<0.001
Non-Compliance with Guidelines (All)	56	9.0%	21.3%	29	8.3%	23.4%	21	9.9%	18.9%	1	5.3%	7.7%	5	12.2%	33.3%	0.9
Non-Complaince with Screening	9	1.4%	3.4%	4	1.1%	3.2%	4	1.9%	3.6%	1	5.3%	7.7%	0	0.0%	0.0%	0.6
Non-Compliance with Follow-Up†	45	7.2%	17.1%	23	6.6%	18.5%	17	8.0%	15.3%	0	0.0%	0.0%	5	12.2%	33.3%	0.1
Non-Compliance with Screening and Follow-Up	2	0.3%	0.8%	2	0.6%	1.6%	0	0.0%	0.0%	0	0.0%	0.0%	0	0.0%	0.0%	0.6
Mixed**	6	1.0%	2.3%	1	0.3%	0.8%	5	2.4%	4.5%	0	0.0%	0.0%	0	0.0%	0.0%	0.3

^**Several possible explanations

‘column percentage among non-prevalent cancers

^*Fisher’s exact test for differences for a correlate by histology category among non-prevalent cancers

^‡The histology of microinvasive cancers was not available

^†Includes failure to come back for follow-up testing, colposcopy, treatment, or post-treatment surveillance according to recommendations